Multiple Sclerosis
FY22 Clinical Trial Award - Funding Level 2
The list of Fiscal Year 2022 Multiple Sclerosis Research Program Clinical Trial Award - Funding Level 2 applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
Institution | Principal Investigator |
---|---|
Accelerated Cure Project, Inc. | Robert McBurney |
Last updated Monday, March 6, 2023